MedinGlobal

Edit Template

ATAZOR-R

In Stock

ATAZOR-R contains Atazanavir 300 mg and Ritonavir 100 mg. It is listed under the antiviral category as a boosted protease inhibitor and is associated with the treatment of HIV-1 infection in combination with other antiretroviral medicines. Product identity, approved indication and suitability should be confirmed against the manufacturer’s pack and prescribing information. Medinglobal receives medicine enquiries and may coordinate product information requests with independent, appropriately authorized providers. An enquiry does not guarantee availability or supply.

ATAZOR-R – Composition, Uses and Medicine Enquiries

Product Overview

ATAZOR-R is listed under the antiviral category and belongs to the antiretroviral, boosted protease inhibitor class. Its active composition is Atazanavir 300 mg + Ritonavir 100 mg. It is associated with HIV-1 infection in combination with other antiretroviral medicines.

The supplied product information describes ritonavir as increasing atazanavir exposure, while atazanavir acts by blocking viral protease. Suitability depends on the diagnosis, approved product labeling, clinical history and specialist assessment. This information is provided for education and product identification and is not a recommendation to begin treatment.

The supplied information also notes that this product is not a complete HIV regimen by itself.

Composition and Strength

Product Name Generic Name Brand Name Strength
ATAZOR-R Atazanavir + Ritonavir ATAZOR-R Atazanavir 300 mg + Ritonavir 100 mg

Therapeutic Category and Indication

  • Therapeutic Category: Antiviral
  • Medicine Class: Antiretroviral; boosted protease inhibitor
  • Associated Indication: HIV-1 infection in combination with other antiretroviral medicines

The exact brand-specific approval and indication should be checked against the manufacturer’s approved product information before publication.

Administration Information

The supplied information describes oral administration with food as directed within the complete HIV regimen. Follow the exact prescribed route, dose and schedule. Do not change, share or discontinue treatment without consulting the treating professional. Refer to the manufacturer’s instructions for product-specific administration information.

Product Presentation and Availability

  • Product: ATAZOR-R
  • Active Composition: Atazanavir 300 mg + Ritonavir 100 mg
  • Listed Manufacturer/Marketer: Emcure Pharmaceuticals Ltd — attribution requires independent verification
  • Dosage Form and Pack Size: Verify from the actual manufacturer pack

The current pack size, labeling, batch details and expiry should be independently checked. No particular packaging, stock or delivery is promised by Medinglobal.

Prescription and Patient Safety

The supplied information highlights bilirubin levels, liver disease, acid-reducing medicines and potential drug interactions as safety considerations. This list is not exhaustive. A qualified clinician should assess the patient’s medical history, other medicines and the applicable prescribing information before treatment decisions.

ATAZOR-R should not be treated as a complete HIV treatment regimen by itself. Its use must be assessed as part of the prescribed antiretroviral regimen.

Medicine Enquiry Coordination Through Medinglobal

Medinglobal receives enquiries about ATAZOR-R and may coordinate requests for product information with independent, appropriately authorized pharmaceutical providers.

Medinglobal is not the manufacturer, direct seller, dispensing pharmacy or exporter of this product. Any permitted transaction, prescription check, destination-country assessment, supply terms and supporting documentation are handled by the relevant authorized provider. An enquiry does not guarantee availability or supply.

How to Submit an ATAZOR-R Enquiry

Submit the brand name, strength, formulation, requested quantity and destination country through Medinglobal’s medicine enquiry channel. Include a valid prescription or institutional documents when required.

An appropriately authorized independent provider must independently confirm product identity, applicable legal requirements and any commercial terms.

Frequently Asked Questions

What is ATAZOR-R used for?

It is associated with HIV-1 infection in combination with other antiretroviral medicines, subject to the exact approved product label and medical assessment.

What does ATAZOR-R contain?

It contains Atazanavir 300 mg + Ritonavir 100 mg. Confirm the final composition against the manufacturer’s pack.

How is ATAZOR-R administered?

The supplied information describes oral administration with food as directed within the complete HIV regimen. Follow the treating clinician’s instructions.

Is ATAZOR-R a complete HIV treatment regimen by itself?

No. The supplied product information states that it is used in combination with other antiretroviral medicines.

Can I request product information through Medinglobal?

Yes. Medinglobal can receive a coordination enquiry, but supply is neither guaranteed nor directly undertaken by Medinglobal.

Product Name

Generic Name

Brand Name

Composition

Strength

Therapeutic Category

Medicine Class

Indication

Dosage Form

Route of Administration

Reviews

There are no reviews yet.

Be the first to review “ATAZOR-R”

Your email address will not be published. Required fields are marked *

Pharmaceutical Disclaimer

Medinglobal Platform does not sell, dispense, manufacture or prescribe medicines. Pharmaceutical information on this page is provided solely for general information, product identification and enquiry coordination. Product listing is not medical advice, a recommendation or an offer for sale by Teji Radiance or the Medinglobal Partnership Firm. Prescription medicines require a valid prescription where applicable. Any regulated pharmaceutical activity is undertaken by the relevant independent provider subject to applicable law. Always consult an appropriately qualified healthcare professional before using or changing any medicine.

Scroll to Top